MediXall Income Statement (2013-2024) | MDXL

Income Statement Dec2013 Mar2014 Jun2014 Sep2014 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024
Revenue & cost
Revenue (Quarter) 0.00M0.17M0.00M0.01M0.01M0.01M0.02M0.02M0.08M0.07M0.07M0.09M0.12M0.05M0.04M
Cost of Revenue (Quarter) 0.09M0.04M0.06M0.05M0.05M0.01M0.02M
Gross Profit (Quarter) 0.01M0.01M0.02M0.02M-0.01M0.04M0.00M0.05M0.07M0.04M0.02M
Operating items
Other Operating Expenses (Quarter) 0.21M0.17M0.18M0.16M2.82M1.85M1.15M0.97M1.97M1.34M1.83M1.39M1.82M2.42M1.56M1.10M1.80M1.21M1.02M0.91M1.50M0.55M0.52M-0.24M
Operating Expenses (Quarter) 0.21M0.17M0.18M0.16M2.82M1.85M1.15M0.97M1.97M1.34M1.83M1.39M1.82M2.42M1.56M1.10M1.80M1.21M1.02M0.91M1.50M0.55M0.52M-0.24M
Operating Income (Quarter) -0.21M-0.17M-0.18M-0.16M1.32M-2.41M-1.55M-1.08M-1.78M-1.22M-0.98M-0.91M-1.45M-0.49M-0.49M0.26M
EBIT (Quarter) -0.21M-0.17M-0.18M-0.16M1.32M-1.85M-1.15M-0.97M-1.97M-1.33M-1.66M-1.39M-1.82M-2.41M-1.55M-1.08M-1.78M-1.22M-0.98M-0.91M-1.45M-0.49M-0.49M0.26M
Non-operating items
Non Operating Investment Income (Quarter) -0.10M
Non Operating Income (Quarter) -0.10M
Net income details
EBT (Quarter) -0.21M-0.17M-0.28M-0.16M-2.82M-1.85M-1.15M-0.97M-1.97M-1.33M-1.66M-1.39M-1.82M-2.41M-1.55M-1.08M-1.78M-1.22M-0.98M-0.91M-1.45M-0.49M-0.49M0.26M
Profit After Tax (Quarter) -0.21M-0.17M-0.28M-0.16M-2.82M-1.85M-1.15M-0.97M-1.97M-1.33M-1.66M-1.39M-1.82M-2.41M-1.55M-1.08M-1.78M-1.22M-0.98M-0.91M-1.45M-0.49M-0.49M0.26M
Income from Continuing Operations (Quarter) -0.21M-0.17M-0.28M-0.16M-2.82M-1.85M-1.15M-0.97M-1.97M-1.33M-1.66M-1.39M-1.82M-2.41M-1.55M-1.08M-1.78M-1.22M-0.98M-0.91M-1.45M-0.49M-0.49M0.26M
Consolidated Net Income (Quarter) -0.21M-0.17M-0.28M-0.16M-2.82M-1.85M-1.15M-0.97M-1.97M-1.33M-1.66M-1.39M-1.82M-2.41M-1.55M-1.08M-1.78M-1.22M-0.98M-0.91M-1.45M-0.49M-0.49M0.26M
Income towards Parent Company (Quarter) -0.21M-0.17M-0.28M-0.16M-2.82M-1.85M-1.15M-0.97M-1.97M-1.33M-1.66M-1.39M-1.82M-2.41M-1.55M-1.08M-1.78M-1.22M-0.98M-0.91M-1.45M-0.49M-0.49M0.26M
Preferred Dividend Payments (Quarter) 0.05M0.06M0.07M0.04M0.07M0.07M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.03M
Net Income towards Common Stockholders (Quarter) -0.21M-0.17M-0.28M-0.16M-2.82M-1.85M-1.15M-0.97M-1.97M-1.33M-1.72M-1.46M-1.85M-2.48M-1.63M-1.16M-1.86M-1.30M-1.06M-0.99M-1.53M-0.56M-0.56M0.23M
Additional items
EPS (Basic) (Quarter) -0.010.00-0.010.00-0.02-0.02-0.01-0.01-0.03-0.01-0.02-0.01-0.02-0.02-0.01-0.01-0.01-0.01-0.01-0.01-0.010.000.000.00
EPS (Weighted Average and Diluted) (Quarter) -0.02-0.01-0.02-0.02-0.01-0.01-0.01-0.01-0.01-0.01-0.010.000.000.00
Shares Outstanding (Weighted Average) (Quarter) 34.22M37.76M37.76M37.79M74.13M84.67M87.75M93.51M90.63M-0.01101.18M105.95M104.20M114.63M115.39M115.90M116.66M122.19M127.45M130.49M127.17M134.04M136.44M145.11M
Shares Outstanding (Diluted Average) (Quarter) 101.18M103.15M104.20M114.63M115.39M116.89M116.66M122.19M127.45M126.05M127.17M134.04M138.83M145.11M
EBITDA (Quarter) -0.21M-0.17M-0.18M-0.16M1.32M-1.85M-1.15M-0.97M-1.97M-1.33M-1.66M-1.39M-1.82M-2.41M-1.55M-1.08M-1.78M-1.22M-0.98M-0.91M-1.45M-0.49M-0.49M0.26M
Interest Expenses (Quarter) 0.27M0.10M0.03M0.04M0.48M0.18M0.11M0.05M